Shares in Bio-Rad dropped 16.8 percent for the five-day trading period ended Tuesday. The firm’s shares took a hit due to an underwhelming financial forecast during its fourth-quarter conference call last week (see related article, this issue), and a drop in stocks across the board. Luminex was the other member of the BCW Index to decline by double-digit figures, falling 11.1 percent for the tracking period.
Twenty of the 22 firms in the Index lost value for the week, with only Bruker and Stratagene gaining ground. Bruker closed the week up 6.8 percent, while Stratagene gained 3.2 percent.
Overall, the Index fell 5.5 percent, a steeper drop than the comparator indices. The Dow Jones Industrial Average fell 4.3 percent for the week, while the Nasdaq dropped 4.2 percent, and the Nasdaq Biotech Index declined 4.4 percent.
|
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies |
||||
| Company |
Ticker
|
Closing Price (Feb. 27, 2007)
|
Starting Price Jan. (Feb. 20, 2007)
|
% change
|
| Affymetrix |
AFFX
|
25.94
|
28.23
|
-8.11
|
| Agilent |
A
|
32.15
|
32.49
|
-1.05
|
| Applied Biosystems |
ABI
|
31.15
|
32.5
|
-4.15
|
| Beckman |
BEC
|
64.74
|
66.25
|
-2.28
|
| Becton Dickinson |
BDX
|
74.75
|
77.5
|
-3.55
|
| Bio-Rad |
BIO
|
71.76
|
86.24
|
-16.79
|
| Bruker |
BRKR
|
8.99
|
8.42
|
6.77
|
| Caliper |
CALP
|
5.99
|
6.2
|
-3.39
|
| Cepheid |
CPHD
|
8.27
|
8.75
|
-5.49
|
| Illumina |
ILMN
|
33.64
|
37.07
|
-9.25
|
| Invitrogen |
IVGN
|
64.35
|
66.39
|
-3.07
|
| Luminex |
LMNX
|
14.07
|
15.82
|
-11.06
|
| Millipore |
MIL
|
71.68
|
74.46
|
-3.73
|
| Molecular Devices |
MDCC
|
35.26
|
35.28
|
-0.06
|
| PerkinElmer |
PKI
|
23.69
|
24.54
|
-3.46
|
| Qiagen |
QGEN
|
16.48
|
17.48
|
-5.72
|
| Sequenom |
SQNM
|
4.1
|
4.52
|
-9.29
|
| Sigma-Aldrich |
SIAL
|
41.35
|
42.3
|
-2.25
|
| Stratagene |
STGN
|
8.47
|
8.21
|
3.17
|
| Thermo |
TMO
|
45.59
|
47.95
|
-4.92
|
| Third Wave |
TWTI
|
5.46
|
5.83
|
-6.35
|
| Waters |
WAT
|
54.15
|
58.4
|
-7.28
|
| BCW Index Average |
33.73
|
35.67
|
-5.45
|
|